Dr. Jalal Nafach

Dr. Jalal Nafach is a consultant endocrinologist at Dubai Health with over two decades of clinical experience in diabetes and metabolic disease management. He trained in internal medicine at McLaren Health Care in the United States before completing a clinical fellowship in endocrinology, diabetes and metabolism at the University of Nebraska. He holds board certifications from the American Board of Internal Medicine (2000) and the American Board of Endocrinology, Diabetes and Metabolism (2002), and has practiced across both the United States and the UAE.

Dr. Nafach's clinical focus is on managing type 2 diabetes and related metabolic conditions. He has particular expertise in evaluating newer drug therapies, including sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) agents, and has contributed to published research assessing their real-world effectiveness and safety in diverse patient populations. His work examines both glycemic control and weight management outcomes.

He is a good fit for patients seeking specialist care in diabetes management, particularly those interested in evidence-based approaches to newer medications or those with inadequately controlled blood sugar despite standard treatment.